secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMGEN INC (AMGN)
CIK:        0000318154
Form:       8-K
Filed at:   2023-01-31T23:59:59+00:00
Accession:  0000318154-23-000011
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amgen posts flat Q4 revenue $6.8B, GAAP EPS down 11%; FTC extends HSR review for Horizon deal
--------------------------------------------------------------------------------

- GAAP EPS $3.00 (down 11% YoY); non-GAAP EPS $4.09 (down 7% YoY).
- Total revenue $6.8B unchanged; product sales +4% with 10% volume growth.
- Full year 2022 revenue $26.3B (+1%), GAAP EPS $12.11, non-GAAP EPS $17.69.
- FTC issued Second Request for Horizon acquisition, extending HSR waiting period 30 days after compliance.
- 2023 guidance provided excluding Horizon; free cash flow $8.8B for full year 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318154/000031815423000011/0000318154-23-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318154/000031815423000011/amgn-20230130.htm
  HTML page:      https://secwatch.observer/filing/0000318154-23-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer